4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0000950170-24-106866
Director acquired 6,165,428 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mazumdar-Shaw Kiran Director | 2024-09-16 | Conversion | +4,327,365 | 4,443,122 | I | ||
| Mazumdar-Shaw Kiran Director | 2024-09-16 | Conversion | +1,080,775 | 1,080,775 | I | ||
| Mazumdar-Shaw Kiran Director | 2024-09-16 | Conversion | +324,552 | 324,552 | I | ||
| Mazumdar-Shaw Kiran Director | 2024-09-16 | Conversion | +432,736 | 432,736 | I | ||
| Derivatives | |||||||
| Mazumdar-Shaw Kiran Director | 2024-09-12 | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | D | ||
| Mazumdar-Shaw Kiran Director | 2024-09-16 | Conversion · Series Seed Redeemable Convertible Preferred Stock | −40,000,000 | 0 | I | ||
| Mazumdar-Shaw Kiran Director | 2024-09-16 | Conversion · Series Seed Redeemable Convertible Preferred Stock | −9,990,144 | 0 | I | ||
| Mazumdar-Shaw Kiran Director | 2024-09-16 | Conversion · Series Seed Redeemable Convertible Preferred Stock | −3,000,000 | 0 | I | ||
| Mazumdar-Shaw Kiran Director | 2024-09-16 | Conversion · Series Seed Redeemable Convertible Preferred Stock | −4,000,000 | 0 | I | ||
Loading xslF345X05/ownership.xml…